None listed
Conditions
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ECOG performance status 0-1 Patients scheduled to undergo ESD due to gastric tumor (dysplasia, early gastric cancer) Patients who are expected to have an iatrogenic ulcer size of 40mm or more after endoscopic submucosal dissection, or are taking aspirin, antiplatelet drugs, or anticoagulants Patients who show adequate patient compliance and have adequate geographic distance for follow-up observation.
Exclusion criteria
Exclusion criteria: Patients with a history of allergies to fibring or administrative prohibitions among PPI's licensed items. Patients who are scheduled to receive ESD for Multiplexion. Pregnant or breastfeeding People with acute or acquired hemorrhagic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total bleeding rate within 60 days of post-treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of post-treatment bleeding in ESD patients with non-stop and temporarily suspended anticoagulant anticoagulants | — |
Countries
Korea, Republic of
Contacts
Public ContactMin Yangwon
Samsung Medical Center
Outcome results
None listed